Randomized controlled trial of intralesional corticosteroid and @entity3101 vs. XXXX alone for treatment of kerion.

@entity1 @entity3071 @entity66 @entity3101 @entity134 @entity3100
We studied 30 @entity1 with @entity3100 and @entity66 and to compare the efficacy of intralesional @entity134 injection and @entity3101 to @entity3101 alone for treatment of this disorder. @entity1 ranged in age from 1 year to 12 years, 1 month (mean, 5 years, 7 months). All @entity1 were black and 23 (77%) were female. (The racial composition of our clinic population is 45% black, 18% Latin American, 34% Caucasian and 3% Asian.) Fungus cultures were positive in all but one @entity1 and Trichophyton tonsurans was isolated from 26 of 30 (87%) of the pretreatment hair cultures. Direct microscopic examinations of @entity3071 -treated hair samples were negative in 13 of 29 (43%) culture-positive @entity1 . @entity1 were randomly assigned to receive intralesional steroid injection (2.5 mg) and @entity3101 (14 @entity1 ) or @entity3101 only (16 @entity1 ). The treatment groups were comparable with regard to age, sex, duration of lesions before treatment and type of lesions. There were no significant differences between the two treatment groups in the time to negative culture, time of onset of new hair growth, complete regrowth of hair and time to scalp clearing. We conclude that intralesional injection of corticosteroid is an unnecessary adjunct to therapy for @entity1 with @entity3100 with kerion.
